NASDAQ:SAGE
Delisted

Sage Therapeutics Stock Signals

etoro logo Buy SAGE
*Your capital is at risk
$8.68
+0 (+0%)
At Close: Oct 30, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Sage Therapeutics

General

Signal Type Signal Value Data
Score 0.000 64 days ( 0 %
Last Price $8.68 0 %
Performance History
7 Days
$8.68 $8.68
0%
30 Days
$8.68 $8.68
0%
12 Mos
$6.44 $8.68
34.78%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $8.68 - $8.68
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Oct 29, 2025 - 2 days
RSI Short Pivot Signal Buy Very Low Aug 12, 2025 - 57 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 42.91
Signal Type Signal Value Importance Data
Trend - 12 mos 48.76 % Very High Width: 35.46 %
Pred. range - 12 mos $11.85 - $16.05 High 36.52 % - 84.94 %
Short MA 12 mos Sell Very High Jul 15, 2025 - 77 days
Long MA 12 mos Sell Very High Oct 27, 2025 - 4 days
Short/Long MA 12 mos Sell Very High Oct 27, 2025 - 4 days
Pivot Long Buy Low Jul 30, 2025 - 66 days
RSI Long Pivot Signal Buy Low Aug 21, 2025 - 50 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT SAGE THERAPEUTICS
Sage Therapeutics
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive steroid, which is in Phase III clinical trials for treating PPD, major depressive disorders, treatment...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
7.38% Jun 05
TPR
$140.47
3.67% Jun 04
N
NVRI
$19.53
8.19% May 20
SAP
$172.39
3.79% May 05
GLBE
$31.61
2.44% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE